Rapamycin: Friend, foe, or misunderstood?

被引：20

作者：

Fung, J ^{[1
]}

Marcos, A ^{[1
]}

机构：

[1] Univ Pittsburgh, Thomas Starzl Transplantat Inst, Pittsburgh, PA 15213 USA

来源：

LIVER TRANSPLANTATION | 2003年 / 9卷 / 05期

关键词：

D O I：

10.1053/jlts.2003.50101

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：469 / 472

页数：4

共 19 条

[1]

ALLEN RDM, 1987, SURG GYNECOL OBSTET, V164, P137

[2] Sirolimus as primary immunosuppression in liver transplantation is not associated with hepatic artery or wound complications [J].

Dunkelberg, JC ;

Trotter, JF ;

Wachs, M ;

Bak, T ;

Kugelmas, M ;

Steinberg, T ;

Everson, GT ;

Kam, I .

LIVER TRANSPLANTATION, 2003, 9 (05) :463-468

[3] EFFECTS OF RAPAMYCIN ON CULTURED HEPATOCYTE PROLIFERATION AND GENE-EXPRESSION [J].

FRANCAVILLA, A ;

CARR, BI ;

STARZL, TE ;

AZZARONE, A ;

CARRIERI, G ;

ZENG, QH .

HEPATOLOGY, 1992, 15 (05) :871-877

[4] Sirolimus (rapamycin)-based therapy in human renal transplantation -: Similar efficacy and different toxicity compared with cyclosporine [J].

Groth, CG ;

Bäckman, L ;

Morales, JM ;

Calne, R ;

Kreis, H ;

Lang, P ;

Touraine, JL ;

Claesson, K ;

Campistol, JM ;

Durand, D ;

Wramner, L ;

Brattström, C ;

Charpentier, B .

TRANSPLANTATION, 1999, 67 (07) :1036-1042

[5] THROMBOEMBOLIC COMPLICATIONS IN RENAL-ALLOGRAFT RECIPIENTS - A REPORT FROM THE PROSPECTIVE RANDOMIZED STUDY OF CYCLOSPORINE VERSUS AZATHIOPRINE-ANTILYMPHOCYTE GLOBULIN [J].

GRUBER, SA ;

PESCOVITZ, MD ;

SIMMONS, RL ;

NAJARIAN, JS ;

ASCHER, NL ;

PAYNE, WD ;

SUTHERLAND, DER ;

FRYD, DS .

TRANSPLANTATION, 1987, 44 (06) :775-778

[6] Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study [J].

Kahan, BD .

LANCET, 2000, 356 (9225) :194-202

[7]

KINGBIGGS MB, IN PRESS TRANSPLANTA

[8] Altered flow properties of blood and increased plasma fibrinogen in cyclosporin-treated renal allograft recipients [J].

Linde, T ;

Sandhagen, B ;

Backman, U ;

Fellström, B .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (06) :1525-1529

[9] A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts [J].

MacDonald, AS .

TRANSPLANTATION, 2001, 71 (02) :271-280

[10] The interrelationship between portal and arterial blood flow after adult living donor liver transplantation [J].

Marcos, A ;

Olzinski, AT ;

Ham, JM ;

Fisher, RA ;

Posner, MP .

TRANSPLANTATION, 2000, 70 (12) :1697-1703

← 1 2 →